Fewer than half of studies conducted on effect of medications on children are published

NewsGuard 100/100 Score

Fewer than half of studies conducted on the effects of prescription drugs in children are published in medical journals, according to a study published Wednesday in the Journal of the American Medical Association, the AP/Lexington Herald-Leader reports.

Study authors Danny Benjamin, an associate professor at Duke University, and Dianne Murphy, director of FDA's office of pediatric therapeutics, examined the impact of a 1997 FDA program that granted longer patent protection to drug companies if they engage in studies involving drugs and children.

The researchers found that between the years 1998 and 2004, 253 pediatric studies were submitted to FDA under the program, but only 45% were published in peer-reviewed journals.

Benjamin said the research does not get published mainly because researchers and sponsors do not submit it for publication.

According to Benjamin, drug companies are mostly motivated to market their drug, "not to tend to the public health concerns."

The researchers also noted that parents can be hesitant to enroll their children in studies, and low enrollment can complicate data compiling and submission.

Study authors said the lack of data dissemination could cause doctors to prescribe drugs that could be harmful to children. "We've just got to get the data out to people who are caring for children," Benjamin said.

Peter Lurie of Public Citizen's Health Research Group said drug companies and academics need to promote publishing. "It is really like the tree falling in the woods.

The study is of no use whatsoever if it never reaches the practicing physician," Lurie said.

Scott Lassman of PhRMA said drug companies should not be faulted for not submitting data.

While publishing studies in peer-reviewed journals is "the gold standard for getting information out," he said companies also often release data at medical conferences or on online databases (Tanner, AP/Lexington Herald-Leader, 9/13).

An abstract of the study is available online.

NPR's "Morning Edition" on Wednesday reported on the study. The segment includes comments from Benjamin; Richard Gorman, spokesperson for the American Academy of Pediatrics; and Lassman (Rovner, "Morning Edition," NPR, 9/13). The complete segment is available online in RealPlayer.


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Prenatal cannabis use disorder linked to increased risk of neurodevelopmental disorders in offspring